The notification software startup received backing from strategic investors Twilio, Slack and SendGrid in a $10.1m round that will fund hiring and product development.

Mission Bay Capital has placed a bet on Symbiome, creators of a skin care range intended to emulate our ancestor’s microbiome.

Baxter International scored an exit as dialysis machine developer Outset Medical floated above its range in an upsized offering.

Astellas and Celgene-backed immuno-oncology therapy developer Oncorus has filed to raise up to $86.3m following more than $150m in funding.

Schlumberger returned for the first close of the round, helping the emissions monitoring technology developer take its total funding to $55m.

Small molecule drug developer C4 has fied for a $100m initial public offering, three months after the Dana-Farber Cancer Institute spinout raised a $170m round.

Kraft Group, Roche and Novartis are in line for exits after small molecule drug developer C4 filed for a $100m offering,

The MSU cancer drug spinout has been acquired on the strength of its expertise in proteasome inhibitors and preclinical pipeline.

American Express Ventures returned to reinvest in the financial intelligence provider as part of a series B round announced in tandem with a company rebrand.

Merck Global Health Innovation Fund has contributed to a $47.5m round for AeroSafe Global, which provides cold supply chain services to pharmaceutical clients.